Prouroguanylin (Guanylate cyclase activator 2B, Guanylate cyclase C-activating peptide 2, Guanylate cyclase C-activating peptide II, GCAP-II, Uroguanylin, UGN, GUCA2B)

References to Prouroguanylin (Guanylate cyclase activator 2B, Guanylate cyclase C-activating peptide 2, Guanylate cyclase C-activating peptide II, GCAP-II, Uroguanylin, UGN, GUCA2B)

Back to Prouroguanylin (Guanylate cyclase activator 2B, Guanylate cyclase C-activating peptide 2, Guanylate cyclase C-activating peptide II, GCAP-II, Uroguanylin, UGN, GUCA2B)

Fan X. Wang Y, London RM, Eber SL, Krause WJ, Freeman RH, Forte LR: Signaling Pathways for Guanylin and Uroguanyiln in the Digestive, Renal, Central Nervous, Reproductive, and Lymphoid Systems. Endocrinology 138, 4636–4648 (1997).
Forte LR: A novel role for uroguanylin in the regulation of sodium balance. Am Clin Invest 112, 1138–1141 (2003).
Forte LR, Freeman RH, Krause WJ, London RM: Guanylin peptides: cyclic GMP signalling mechanisms. Braz J med Biol Res 32(11), 1329–1336 (1999).
Forte LR, London RM, Freeman RH, Krause WJ: Guanylin peptides: renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278, 180–191 (2000).
Hamra FK, Fan X, Krause WJ, Freeman RH, Chin DT, Smith ChE, Currie MG, Forte LR: Prouroguanylin and proguanylin: Purification from Colon, Structure, and Modulation of Bioactivity by Proteases. Endocrinology 137, 257–265 (1996).
Hidaka Y, Shimono Ch, Ohno M, Okumura N, Adermann K, Forshmann W-G, Shimonishi Y: Dual Function of the Propeptide of Prouroguanylin in the Folding of the Mature Peptide. J Biol Chem 257, 25155–25162 (2000).
Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y, Joo NS, Kim HD, Miedema BW, Abbas SZ, Boddupalli SS, Currie MG, Forte LR: Uroguanylin Treatment Suppresses Polyp Formation in the APCMin/+ Mouse and Induces Apoptosis in Human Colon Adenocarcinom Cells via Cyclic GMP. Cancer research 60, 5151–5157 (2000).